<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Mol Biochem Parasitol. 2011 January ; 175(1): 58&#226;&#8364;&#8220;67. doi:10.1016/j.molbiopara.2010.09.004. <br />  <br />  <br />  <br />                            Phenylalanine hydroxylase (PAH) lower eukaryote <br />                            Leishmania major <br />  <br />                            Lon-Fye Lyea, Song Ok Kanga, Joshua D. Nosanchukb, Arturo Casadevallb, Stephen M. <br />                            Beverleya,* <br />                            Department Molecular Microbiology, Box 8230, Washington University Medicine School, 600 <br />  <br />                            S. Euclid Ave., St. Louis, MO 63110, USA <br />                            bDepartment Medicine, Albert Einstein College Medicine, 1300 Morris Park Avenue, Bronx, <br />                            New York, NY 10461, USA <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                  Aromatic amino acid hydroxylases (AAAH) typically use tetrahydrobiopterin (H4B) cofactor. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  The protozoan parasite Leishmania major requires biopterin growth expresses strong salvage <br />                                  regeneration systems maintain H4B levels. Here explored consequences genetic <br />                                  manipulation sole L. major phenylalanine hydroxylase (PAH) explore could <br />                                  account Leishmania H4B requirement. L. major PAH resembles AAAHs organisms, <br />                                  bearing eukaryotic-type domain organization, conservation key catalytic residues including <br />                                  implicated pteridine binding. A pah&#226;&#710;&#8217; null mutant episomal complemented <br />                                  overexpressing derivative (pah&#226;&#710;&#8217;/+PAH) readily obtained, metabolic labeling studies <br />                                  established PAH required hydroxylate Phe Tyr. Neither WT overexpressing lines <br />                                  able hydroxylate radiolabeled tyrosine tryptophan, synthesize catecholamines. WT <br />                                  pah&#226;&#710;&#8217; parasites showed reactivity antibody melanin grown L-3,4- <br />                                  dihydroxyphenylalanine (L-DOPA), reactive product unlikely melanin sensu <br />                                  strictu. WT auxotrophic Phe, Trp Tyr, suggesting PAH activity insufficient <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> <br />                                  meet normal Tyr requirements. However, pah&#226;&#710;&#8217; showed increased sensitivity Tyr deprivation, <br />                                  pah&#226;&#710;&#8217;/+PAH overexpressor showed increased <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span>survival</span> adapted grow well <br />                                  added Tyr. pah&#226;&#710;&#8217; showed alterations H4B-dependent differentiation, established by <br />                                  vitro metacyclogenesis, survival mouse macrophage infections. Thus Leishmania PAH <br />                                  mitigate alleviate Tyr auxotrophy, plays essential role steps parasite <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  infectious cycle. These findings suggest PAH unlikely explain Leishmania requirement for <br />                                  biopterin. <br />  <br />  <br />                            Keywords <br />                                  trypanosomatid protozoa; tetrahydrobiopterin; aromatic amino acid hydroxylase; amino acid <br />                                  metabolism; virulence <br />  <br />  <br />  <br />  <br />                            * <br />                            Corresponding author. Tel.: 314-747-2630; Fax: 314-747-2634; beverley@borcim.wustl.edu. <br />                            The nucleotide sequences reported paper submitted GenBank&#226;&#8222;&#162;/EBI Data bank accession number AY273788 <br />                            Publisher&apos;s Disclaimer: This PDF file unedited manuscript accepted publication. As service customers <br />                            providing early version manuscript. The manuscript undergo copyediting, typesetting, review resulting <br />                            proof published final citable form. Please note production process errors discovered could <br />                            affect content, legal disclaimers apply journal pertain. <br />                             Lye et al.                                                                                                   Page 2 <br />  <br />  <br />                                1. Introduction <br />                                            Leishmania genus trypanosomatid protozoan parasites comprising 20 species <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            responsible number severe diseases humans worldwide, infecting 12 million <br />                                            people [1]. Leishmania transmitted bite Phlebotomine sand flies, the <br />                                            mammalian host reside primarily acidified phagolysosome macrophages, they <br />                                            deflect host defenses immune responses order survive [2]. As deep-branching <br />                                            eukaryotic lineage, Leishmania exhibits considerable divergence metabolic enzyme <br />                                            repertoire [3], providing opportunities basic studies practical efforts towards <br />                                            improved chemotherapy. <br />  <br />                                            Here focus genetic studies null overexpression mutants sole Leishmania <br />                                            gene related aromatic amino acid hydroxylases (AAAH). Our AAAHs arose <br />                                            cofactor biopterin essential growth factor, distinct folate, several <br />                                            trypanosomatid species. In mammals tetrahydrobiopterin (H4B) required enzymes <br />                                            critical metabolic importance, including amino acid hydroxylases (AAAHs), nitric oxide <br />                                            synthase ether lipid cleavage monooxygenase [reviewed 4,5]. Leishmania other <br />                                            trypanosomatids general auxotrophs pteridines [6,7], acquire biopterin the <br />                                            host salvage, uptake transporter BT1 [8,9] reduction H4B the <br />                                            broad spectrum pteridine reductase PTR1 [10, reviewed 11,12]. The direct pteridine product <br />                                            AAAH action 4&#206;&#177;-OH-H4B (carbinolamine) returned H4B the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            successive action pteridine-4-carbinolamine dehydratase (PCD) quininoid <br />                                            dihydropteridine reductase [QDPR; 4]. Trypanosomatids encode functional forms both <br />                                            genes [13,14]. <br />  <br />                                            Despite knowledge H4B metabolism requirements Leishmania, essential <br />                                            metabolic role H4B established [15]. In species, AAAH activity requires the <br />                                            amino acid substrate, molecular oxygen, reduced cofactor H4B [(6R)-L- <br />                                            erythro-5,6,7,8-tetrahydropterin; 16]. AAAHs catalyze conversion phenylalanine, <br />                                            tyrosine and/or tryptophan tyrosine, 3,4-dihydroxyphenylalanine (L-DOPA), 5- <br />                                            hydroxytryptophan respectively. Typically activities carried different <br />                                            enzymes, phenylalanine hydroxylase (PAH; EC 1.14.16.1), tyrosine hydroxylase (TyrH; EC <br />                                            1.14.16.2) tryptophan hydroxylase (TrpH; EC 1.14.16.4), organisms <br />                                            hydroxylases broader specificities [reviewed 16,17]. AAAH widespread <br />                                            evolution, prokaryotes, protozoans, plants, fungi, animals. In metazoans <br />                                            AAAH play critical roles metabolism neurotransmitter synthesis, PAH participates <br />                                            Phe catabolism bacteria [18]. <br />  <br />                                            The identification putative H4B-dependent AAAH Leishmania genome raised the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            possibility activity account H4B biopterin requirement. We report here <br />                                            studies confirm activity Phe hydroxylase (PAH) L. major, characterize its <br />                                            role parasite metabolism infectivity. <br />  <br />                                2. Materials methods <br />                                2.1. Chemicals reagents <br />                                            Dihydrobiopterin (H2B) Schircks Laboratories (Jona, Switzerland). Biopterin, <br />                                            epinephrine, norepinephrine, propanolol RPMI 1640 vitamin solutions Sigma- <br />                                            Aldrich (St. Louis, USA). L-[5-H3] tryptophan, L-[3, 5-H3] tyrosine, L-[2, 6-H3] <br />                                            phenylalanine) obtained Amersham Biosciences Corp. Phenol red solution and <br />                                            penicillin/streptomycin Invitrogen. Fetal calf serum purchased Bio- <br />                                            Whittaker bovine serum albumin (Fraction V) U. S. Biochemical Corp. M199 with <br />                                            Hanks s salts US Biologicals. Folate-deficient medium (fdM199) custom <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                Page 3 <br />  <br />  <br />                                            manufactured Invitrogen identical M199 lacking folate thymidine <br />                                            [19]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                2.2. Parasite growth media <br />                                            L. major Friedlin V1 (MHOM/JL/80/Friedlin) recovered infected animals used <br />                                            10 serial passages vitro. Promastigotes grown M199 medium supplemented <br />                                            10 % heat-inactivated fetal bovine serum 26&#194;&#176;C [19]; routine culture 2 &#206;&#188;g ml&#226;&#710;&#8217;1 <br />                                            biopterin added. Metacyclic promastigotes purified stationary phase cells <br />                                            using negative agglutination assay [20]. Amastigotes harvested BALB/c mice <br />                                            footpad lesion 3 weeks post infection. <br />  <br />                                            In experiments cells grown fdM199 (M199 medium lacking folate thymidine <br />                                            supplemented 0.66 % bovine serum albumin serum). To deplete internal levels <br />                                            biopterin, WT KO cells grown fdM199 medium lacking biopterin three <br />                                            passages (dilution cells ~ 2 &#195;&#8212; 105/ml growth stationary phase 2 &#195;&#8212; 107/ <br />                                            ml). For differentiation, biopterin-depleted cells incubated cell density 2 &#195;&#8212; 105 <br />                                            cells/ml fdM199 medium supplemented biopterin (0.001 &#206;&#188;g ml&#226;&#710;&#8217;1 2 &#206;&#188;g ml&#226;&#710;&#8217;1), or <br />                                            biopterin plus 100 &#206;&#188;M epinephrine, 100 &#206;&#188;M norepinephrine 10 &#206;&#188;M propanolol. <br />                                            Alternatively, RPMI 1640 based medium used, containing 1 % fetal bovine serum, 40 <br />                                            mM Hepes pH 7.4, 1X RPMI 1640 vitamin mix, 1X amino acid mixtures (lacking Phe, Tyr or <br />                                            Trp), 100 &#206;&#188;M adenine, 1 &#206;&#188;g ml&#226;&#710;&#8217;1biotin, 5 &#206;&#188;g ml&#226;&#710;&#8217;1 hemin, 50 U ml&#226;&#710;&#8217;1 penicillin, 50 &#206;&#188;g <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            ml&#226;&#710;&#8217; 1streptomycin, 2 &#206;&#188;g ml&#226;&#710;&#8217;1 biopterin, 5.37 mM KCl, 0.42 mM Ca(NO3)2&#226;&#8364;&#162;4H2O, 102.67 mM <br />                                            NaCl, 5.63 mM Na2HPO4, 0.41 mM MgSO4&#226;&#8364;&#162;7H2O, 23.81 mM NaHCO3, 11.11 mM glucose, <br />                                            0.0005% phenol red. Complete media additionally contained Phe (91 &#206;&#188;M), Tyr (111 &#206;&#188;M) <br />                                            Trp (24 &#206;&#188;M). <br />  <br />                                2.3. Southern Northern blot analysis <br />                                            L. major FV1 genomic DNA isolated late logarithmic phase promastigotes by <br />                                            LiCl method [22]. Genomic DNA digested appropriate restriction enzymes <br />                                            electrophoreses 0.8 % agarose gels transferred nylon membranes. Total RNA of <br />                                            L. major promastigotes amastigotes isolated using phenol/guanidine <br />                                            isothiocyanate reagent TRIzol&#226;&#8222;&#162; (Invitrogen) according manufacturer&#226;&#8364;&#8482;s instructions. <br />                                            Southern Northern performed following standard procedures hybridization <br />                                            probes labeled [&#206;&#177;-32P] dCTP random-priming [23]. <br />  <br />                                2.4. PAH gene cloning sequencing <br />                                            A PCR fragment spanning 870 nt 953 nt PAH ORF) obtained PCR <br />                                            amplification (primers SMB1076 5&#226;&#8364;&#178;-GCCGGACATGGTTCACGACATCand SMB1077 5&#226;&#8364;&#178;- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            AGGCCGATCGTCTGGGTGAAG)and GSS clone lm94b04 [24] DNA template. This DNA <br />                                            radiolabeled used screen L. major Friedlin V1 cosmid library [25]. Three different <br />                                            cosmid clones containing PAH gene obtained (c11p6, strain B4089; c10m17, strain <br />                                            B4086; c9o9, strain B4087). Following subcloning mapping, sequence PAH was <br />                                            determined using ABI PRISM &#226;&#8222;&#162; BigDye Terminator Cycle Sequencing Ready Reaction <br />                                            kit (PE Applied Biosystems, Foster City, CA). <br />  <br />                                2.5. Mapping 5&#226;&#8364;&#178; Terminus mature PAH transcript <br />                                            To amplify 5&#226;&#8364;&#178;-end PAH, L. major total RNA used template RT-PCR. Reverse <br />                                            transcription performed Superscript II reverse transcriptase (Invitrogen) following <br />                                            manufacturer&#226;&#8364;&#8482;s protocol. PCR performed using Taq polymerase (Roche) 30 cycles <br />                                            denaturing 94&#194;&#176;C 1 min, annealing 50&#194;&#176;C 1 min extension 72&#194;&#176;C 2 min. <br />                                            Primers specific L. major spliced leader sequence (SMB936: 5&#226;&#8364;&#178;- <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                              Page 4 <br />  <br />  <br />                                             ACCGCTATATAAGTATCAGTTCTGTACTTTA) specific primers, SMB1122 and <br />                                             1117 located PAH coding region (SMB1122: 5&#226;&#8364;&#178;- <br />                                             TGCAGGGACGTGCGGCACCGCG SMB1117: 5&#226;&#8364;&#178;- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             GTCGGGTACAGGCGGGTCAGGT). The PCR products purified sequenced <br />                                             directly. <br />  <br />                                2.6. Overexpression PAH <br />                                             The 1362-nt PAH open reading frame amplified PCR Pfu polymerase (Stratagene) <br />                                             using primers SMB 1155 (5&#226;&#8364;&#178;-GCGGATCCACCATGCTGCTGCGCAGTCGTTTGT; the <br />                                             underline sequence corresponds BamHI site bold nucleotides correspond a <br />                                             &#226;&#8364;&#339;Kozak&#226;&#8364;? sequence), SMB 1156 (5&#226;&#8364;&#178;-CGGGATCCTTAGAAGGTGAAGTTTGTTCGC), and <br />                                             50 ng template genomic DNA. The amplified DNA fragment digested cloned into <br />                                             BamHI site Leishmania expression vector pXG1a [26], yielding pXG-PAH (strain <br />                                             B4193), sequence confirmed. <br />  <br />                                2.7. Molecular constructs replacement PAH alleles transfection <br />                                             The 5&#226;&#8364;&#178;-flanking region PAH gene amplified PCR using primers SMB1589 <br />                                             (5&#226;&#8364;&#178;-CGGGGTACCGACGACAGACGTGCCG) SMB1590 (5&#226;&#8364;&#178;- <br />                                             CCATCGATCTTATTCTCGAGGCAAGTCAGG) adding KpnI/ClaI sites, 3&#226;&#8364;&#178; <br />                                             flanking region PCR amplified using primers SMB1608 1592 adding BamHI/NotI <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             sites. These fragments digested appropriate enzymes inserted successively <br />                                             pBSKII (Promega, Madison, WI), yielding (pBS5&#226;&#8364;&#178;3&#226;&#8364;&#178;PAH). Then, BSD HYG resistance <br />                                             ORFs amplified individually primers SMB1666 (5&#226;&#8364;&#178;- <br />                                             CCCAAGCTTATGGCCAAGCCTTTGTCTCAAGA)/SMB1667 (5&#226;&#8364;&#178;- <br />                                             CGGGATCCTTAGCCCTCCCACACATAACCAG) SMB1665 (5&#226;&#8364;&#178;- <br />                                             CCCAAGCTTATGAAAAAGCCTGAACTCACCGC)/SMB1594 (5&#226;&#8364;&#178;-&#226;&#8364;&#178; <br />                                             CGGGATCCCTATTCCTTTGCCCTCGGACGA) respectively, added HindIII and <br />                                             BamHI sites, templates pXG-HYG [27] pXG-BSD [28]. These fragments were <br />                                             digested appropriately inserted HindIII/BamHI digested pBS5&#226;&#8364;&#178;3&#226;&#8364;&#178;PAH, yielding the <br />                                             final replacement constructs pBS5&#226;&#8364;&#178;BSD3&#226;&#8364;&#178;PAH pBS5&#226;&#8364;&#178;HYG3&#226;&#8364;&#178;PAH (strain B4696, strain <br />                                             B4692). DNAs cut NotI KpnI, targeting fragment purified. WT parasites <br />                                             electroporated PAH::&#206;&#8221;HYG targeting fragment derived B4692 described <br />                                             [21]. Transfectant colonies obtained plating semisolid M199 medium containing <br />                                             hygromycin B (50 &#206;&#188;g/ml), typical frequencies. Three bearing heterozygous replacements <br />                                             (formally PAH/PAH::&#206;&#8221;HYG) passaged animals showed typical <br />                                             infectivity. One (clone 2) selected electroporated PAH::BSD targeting <br />                                             fragment, and, transfectant colonies obtained plating semisolid M199 medium <br />                                             containing blasticidin (10 &#206;&#188;g ml&#226;&#710;&#8217;1) hygromycin B (50 &#206;&#188;g ml&#226;&#710;&#8217;1), normal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             frequencies. Following molecular confirmation lines (formally PAH::&#206;&#8221;HYG/PAH:: <br />                                             &#206;&#8221;BSD, referred pah&#226;&#710;&#8217; hereafter) used infect animals showed typical <br />                                             infectivity, described text. One (KO4) selected and <br />                                             electroporated pXG-PAH, transfectant colonies obtained following plating on <br />                                             semisolid media containing G418 (10 &#206;&#188;g ml&#226;&#710;&#8217;1), blasticidin (10 &#206;&#188;g ml&#226;&#710;&#8217;1) hygromycin B <br />                                             (50 &#206;&#188;g ml&#226;&#710;&#8217;1). Several lines (formally, PAH:: &#206;&#8221;HYG/PAH:: &#206;&#8221;BSD [pXG-PAH], referred as <br />                                             pah&#226;&#710;&#8217;/+PAH hereafter) passaged animals showed typical infectivity, <br />                                             (KO4-AB2) selected. <br />  <br />                                2.8. Metabolic labeling <br />                                             Leishmania major grown M199 medium early log phase (2 &#195;&#8212; 106/ml), harvested <br />                                             centrifugation, washed twice incubated modified RPMI 1640 medium <br />                                             aromatic amino acid contents adjusted follows. For Phe labeling, media contained <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                     Page 5 <br />  <br />  <br />                                             23 &#206;&#188;M Phe 8 &#206;&#188;M Trp, Tyr Trp labeling 23 &#206;&#188;M Phe, 28 &#206;&#188;M Tyr 28 &#206;&#188;M <br />                                             Trp used. Cells resuspended 1 ml medium final concentration 5 &#195;&#8212; 107/ <br />                                             ml, 10 &#206;&#188;l 1 mCi/ml stock radiolabeled L- (2,6-3H) Phenylalanine, L- (3,5-3H) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Tyrosine L- (5-3H) Trytophan added (Phe, 480 Ci/mmol, Tyr 55 Ci/mmol Trp, 32 Ci/ <br />                                             mmol). Cells incubated 2 hrs 26&#194;&#176;C, placed 200 &#206;&#188;l dibutylphthalate <br />                                             centrifuged 14,000 &#195;&#8212; g 2 min. The upper aqueous layer removed, residual <br />                                             surface material removed washing twice 1 ml PBS. The oil layer then <br />                                             removed, cells recovered resuspended 100 &#206;&#188;l PBS. <br />  <br />                                             For total amino acid uptake, 50 &#206;&#188;l suspended cells lysed 200 &#206;&#188;l 1% Triton X-100, <br />                                             added 5 ml Scintiverse II scintillation fluid, used liquid scintillation counting. For <br />                                             HPLC analysis, 50 &#206;&#188;l cell suspension heated 100&#194;&#176; C 10 min, centrifuged at <br />                                             14,000 &#195;&#8212; g 15 min. Then, samples derivatized described [29] some <br />                                             modifications. Briefly, 10&#226;&#8364;&#8220;50 &#206;&#188;l cell lysate mixed 110 &#206;&#188;l borate buffer (0.2 M <br />                                             sodium borate, 1 mM EDTA, pH 8.8) mixed vortexing. Then 40 &#206;&#188;l AccQ-Fluor <br />                                             reagent (N-hydroxysuccinimidyl-6-aminoquinoyl carbamate Waters, USA) added to <br />                                             final volume 200 &#206;&#188;l, sample vortexed vigorously, 50 &#206;&#188;l derivatized <br />                                             sample used chromatography <br />  <br />                                2.9. High performance liquid chromatography (HPLC) <br />                                             A Waters HPLC Millennium software used control, data collection, and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             peak area calculation. HPLC columns buffers used described [29], Waters <br />                                             600E gradient curve shape 7 used instead linear gradient order improve separation <br />                                             norepinephrine valine. Unlabeled amino acids included standards indicated. <br />                                             Fractions collected 1 min intervals, 5 ml Scintiverse II scintillation fluid was <br />                                             added prior liquid scintillation counting. <br />  <br />                                2.10. Immunofluorescence <br />                                             Ten &#206;&#188;l suspensions containing 106 Leishmania cells grown L-DOPA were <br />                                             dried poly-L-lysine-coated slides. The slides washed PBS, incubated in <br />                                             Superblock&#194;&#174; [Pierce, Rockford, IL] blocking buffer 1 h 37&#194;&#176;C followed incubation <br />                                             10 &#206;&#188;g ml&#226;&#710;&#8217;1 melanin-binding monoclonal antibody 6D2 [30] 1 h 37&#194;&#176;C. After <br />                                             washing, slides incubated 1:1000 dilution tetramethyl rhodamine <br />                                             isothiocyanate (TRITC) -conjugated goat anti-mouse IgM (Southern Biotechnologies <br />                                             Associates, Inc; Birmingham, AL) 1 h 37&#194;&#176; C. Slides washed, mounted using 50% <br />                                             glycerol, 50% PBS, 0.1 M N-propyl gallate solution, viewed Olympus AX70 <br />                                             microscope (Melville, NY) equipped TRITC filter. Negative controls incubated <br />                                             mAb 5C11, binds mycobacterial lipoarabinomannan [31] primary Ab, or <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             TRITC-labeled Ab alone. <br />  <br />                                2.11. Melanin isolation <br />                                             Promastigotes suspended 1.0 M sorbitol-0.1 M sodium citrate, pH 5.5. Cell wall lysing <br />                                             enzymes (<span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> Trichoderma harzianum; Sigma-Aldrich, St. Louis) added (10 mg <br />                                             ml&#226;&#710;&#8217;1) suspensions incubated 30&#194;&#176;C overnight. Cells collected by <br />                                             centrifugation, washed PBS, incubated 4 M guanidine thiocyanate 12 h. The <br />                                             particulate treated 1 mg ml&#226;&#710;&#8217;1 proteinase K (10 mM Tris, 1.0 mM CaCl2, 0.5% <br />                                             SDS, pH 7.8) 37&#194;&#176;C overnight extracted times chloroform. The debris <br />                                             collected, washed PBS, boiled 6.0 M HCl 1 h. <br />  <br />  <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                 Page 6 <br />  <br />  <br />                                2.12. Mouse infectivity tests <br />                                             BALB/c mice Charles River Laboratories Inc. (Wilmington, MA) CBA/J mice <br />                                             Jackson Laboratory (Bar Harbor, Me). All studies performed using protocols <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             approved institutional animal studies committee. Parasites grown stationary <br />                                             phase M199 medium, groups BALB/c mice injected subcutaneously (s.c.) into <br />                                             footpads 106, 105, 104 parasites mice [32]. Lesions monitored measuring <br />                                             thickness footpad Vernier caliper. Lesion parasites enumerated the <br />                                             infected tissue limiting dilution assay [33]. <br />  <br />                                2.13. Macrophage Infections <br />                                             Infection peritoneal macrophages C3-opsonized parasites performed described <br />                                             [34]. The medium changed daily, days 1, 2, 3 postinfection, intracellular parasites <br />                                             visualized formaldehyde-fixed macrophages nuclear staining Hoechst 33342 <br />                                             (0.5 &#206;&#188;g ml&#226;&#710;&#8217;1). <br />  <br />                                3. Results <br />                                3.1 Identification properties L. major PAH gene <br />                                             We identified candidate phenylalanine hydroxylase gene blast searches data obtained <br />                                             genome shotgun library [24]. A radiolabeled probe used screen L. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             major cosmid library, relevant regions cosmids sequenced. The gene <br />                                             encoded predicted protein 453 aa/50.4 kDa (Fig. 1) given gene symbol <br />                                             PAH, subsequently shown required PAH activity. Southern blot <br />                                             analysis showed present single copy (Fig. S1), good agreement current <br />                                             L. major genome assembly, PAH bears systematic gene identifier LmjF28.1280 <br />                                             [35]. <br />  <br />                                             L. major PAH displayed overall 42&#226;&#8364;&#8220;51 % identity AAAH mammals, Drosophila <br />                                             C. elegans. Mammalian AAAHs contain variable N terminal domain comprising about <br />                                             1/3 protein mediates regulatory functions, central conserved catalytic domain, and <br />                                             short C-terminal domain mediating oligomerization [reviewed 16,17]. Similarly, LmjPAH <br />                                             showed divergent N terminal domain comprising amino acids 1&#226;&#8364;&#8220;123, conserved <br />                                             catalytic domain comprising amino acids 124&#226;&#8364;&#8220;436, followed divergent C-terminal domain <br />                                             (Fig. 1). Recently PAHs described Toxoplasma gondii, predicted proteins <br />                                             bearing signal sequences potentially indicative secretion [36]. However, L. major PAH lacks <br />                                             N-terminal extension (Fig. 1) computational methods did predict signal <br />                                             sequence Leishmania PAH. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Structural motifs characteristic aromatic amino acid hydroxylases central <br />                                             catalytic region LmjPAH, including iron binding site (His295, His301, Glu331 in <br />                                             LmjPAH) [37], conserved substrate cofactor binding sites (residues 274&#226;&#8364;&#8220;301) [38]. <br />                                             LmjPAH contains Asp position corresponding Glu286 rat PheH, been <br />                                             implicated H4B binding [39]. While amino acid hydroxylases cross&#226;&#710;&#8217;activity to <br />                                             varying extents, studies shown difficult reliably predict amino acid <br />                                             specificity amino acid sequences alone, trends observed [16]. Several <br />                                             amino acid residues determined substrate specific activity tyrosine tryptophan <br />                                             hydroxylase LmPAH. These include position corresponding Y235 <br />                                             F313 tryptophan hydroxylase [40] D425 tyrosine hydroxylase [41]. <br />  <br />                                3.2. Structure expression PAH mRNA infectious cycle <br />                                             In Leishmania related trypanosomatid protozoans, mRNA contains 39-nt &#226;&#8364;&#732;spliced- <br />                                             leader&#226;&#8364;&#8482; 5&#226;&#8364;&#178; end added trans-splicing [42]. We used RT-PCR spliced-leader and <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                  Page 7 <br />  <br />  <br />                                            primers specific PAH map 5&#226;&#8364;&#178; trans-splice acceptor site PAH mRNA an <br />                                            AG dinucleotide 141 nt 5&#226;&#8364;&#178; predicted AUG initiation codon, AUG <br />                                            (data shown). Northern blots revealed single 4 kb transcript stages infectious <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            cycle (early log promastigote, late log promastigote, metacyclic promastigote amastigote) <br />                                            little variation development (Fig. 2). A similar result obtained mRNA <br />                                            encoding H4B regenerating enzyme QDPR [13]. <br />  <br />                                3.3. Generation PAH <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span>null mutants</span> targeted gene deletion <br />                                            We unable express enzymatically active form E. coli, active form in <br />                                            vitro, despite attempts. These included varying expression conditions host cells, tests <br />                                            alternative pteridines including folates, tests truncations removing poorly conserved <br />                                            N terminal &#226;&#8364;&#732;regulatory&#226;&#8364;&#8482; domain, C-terminal domain; such <br />                                            variations proven successful studies species&#226;&#8364;&#8482; AAAH. Thus turned studies <br />                                            PAH null mutants, parasites over-expressing PAH, explore potential roles and <br />                                            activities vivo. <br />  <br />                                            As Leishmania species predominantly diploid, successive rounds gene targeting <br />                                            required generate null mutants [27]. The PAH allele replaced the <br />                                            hygromycin B resistance marker (HYG) second replaced blasticidin <br />                                            (BSD) resistance marker (Fig. 3A). Southern blot analysis PAH probe confirmed that <br />                                            PAH gene completely deleted (Fig. 3C), hybridization flanking probe <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            confirmed replacements occurred planned (Fig. 3D). Notably, homozygous <br />                                            replacement (pah&#226;&#710;&#8217;) lines obtained typical frequencies, grew normally standard <br />                                            M199 culture media thereafter. Several independent lines analyzed, had <br />                                            similar growth properties (not shown). We restored PAH expression transfection an <br />                                            episomal multicopy vector, yielding lines termed pah&#226;&#710;&#8217;/+PAH, additionally exhibit <br />                                            PAH overexpression. <br />  <br />                                3.4. In vivo detection PAH-dependent phenylalanine hydroxylase activity metabolic <br />                                labeling <br />                                            Leishmania grown logarithmic phase, collected, washed twice, inoculated into <br />                                            media containing radiolabeled phenylalanine, tyrosine tryptophan. After 2 hr, samples were <br />                                            collected, deproteinized, separated HPLC addition appropriate standards <br />                                            (Fig. 4A&#226;&#8364;&#8220;C). When labeled [3H]-Phe, WT pah&#226;&#710;&#8217; extracts showed incorporation <br />                                            peak comigrating free Tyr standard (Fig 4A). In contrast, incorporation above <br />                                            background seen using [3H]-Tyr [3H]-Trp, predicted products DOPA 5- <br />                                            hydroxy-tryptophan (Fig. 4B, C). Since limiting concentrations radiolabeled essential amino <br />                                            acids used order maximize specific activity, free amino acids used in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            protein synthesis, preliminary experiments varied time labeling 1 4 h. As <br />                                            metabolism radiolabeled Tyr Trp detected, [3H]-Tyr <br />                                            formation [3H]-Phe maximal 2 hr. Other Tyr formation, differential was <br />                                            seen WT pah&#226;&#710;&#8217;, pah&#226;&#710;&#8217;/+PAH overexpressor (data shown). These <br />                                            data indicate Leishmania PAH required phenylalanine tyrosine or <br />                                            tryptophan hydroxylase activity. Potentially, PAH possess low level tyrosine hydroxylase <br />                                            activity evident studies above. Thus sought unable detect HPLC <br />                                            potential downstream catecholamine metabolites (norepinephrine, epinephrine, dopamine) in <br />                                            WT extracts (Fig 4D). <br />  <br />                                            Total uptake incorporation radiolabeled Phe 2 hr free Phe Tyr were <br />                                            quantified WT, pah&#226;&#710;&#8217; pah&#226;&#710;&#8217;/+PAH lines (Table 1). Total Phe uptake/incorporation <br />                                            somewhat pah&#226;&#710;&#8217; (75% WT) elevated pah&#226;&#710;&#8217;/+PAH (129% WT), these <br />                                            differences significant. Free Phe somewhat reduced pah&#226;&#710;&#8217; (78% WT) more <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                Page 8 <br />  <br />  <br />                                            strongly reduced pah&#226;&#710;&#8217;/+PAH line (27% WT); differences significant. <br />                                            As shown Fig 4A, pah&#226;&#710;&#8217; showed incorporation Phe free Tyr strongly <br />                                            significant (P&lt;0.01), pah&#226;&#710;&#8217;/+PAH showed 2.4-fold increase. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                3.5. PAH aromatic amino acid growth requirements <br />                                            To probe consequences PAH depletion overexpression, parasites inoculated into <br />                                            semidefined medium, lacking phenylalanine, tryptophan tyrosine. The WT and <br />                                            pah&#226;&#710;&#8217; lines incapable sustained proliferation media lacking aromatic acids <br />                                            (Fig. 5A&#226;&#8364;&#8220;C), consistent view Leishmania auxotrophic aromatic amino <br />                                            acids [43]. Unlike WT cells arrested constant cell numbers, pah&#226;&#710;&#8217; showed tendency <br />                                            decreased cell numbers time (Fig. 5A&#226;&#8364;&#8220;C). <br />  <br />                                            After substantial delay ~8 days, pah&#226;&#710;&#8217;/+PAH overexpressor able resume growth <br />                                            Tyr-deficient media, slowly presence Tyr (Fig 5C). These <br />                                            parasites adapted passage Tyr-deficient media (six passages 1:100 serial <br />                                            dilutions), retested. These P6 pah&#226;&#710;&#8217;/+PAH parasites exhibited growth comparable <br />                                            WT presence Tyr (Fig. 5D). Adaptation dependent presence the <br />                                            episomal PAH gene, WT parasites increased rate growth (not shown). The <br />                                            basis adaptation studied dependency episomal PAH suggests that <br />                                            increased plasmid copy number PAH expression account finding, seen <br />                                            originally &#226;&#8364;&#732;super-selections&#226;&#8364;&#8482; L. major episomal vectors [21]. These data provide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            independent confirmation PAH activity PAH, role provision Tyr <br />                                            limiting conditions, alleviation requirement overexpressed. <br />  <br />                                3.6. Infectivity pah&#226;&#710;&#8217; L. major mouse macrophage infections <br />                                            The ability pah&#226;&#710;&#8217; mutant parasites cause lesions susceptible BALB/c mice was <br />                                            investigated inoculating infectious stationary phase promastigotes (104 &#226;&#8364;&#8220; 106) footpads, <br />                                            monitoring parasite-induced pathology measuring footpad thickness time. For the <br />                                            WT, pah&#226;&#710;&#8217; pah&#226;&#710;&#8217;/+PAH lines, difference time lesion pathology <br />                                            appeared, progression lesion pathology (Fig. 6A&#226;&#8364;&#8220;B). Similarly, when <br />                                            inoculated genetically resistant CBA/J mice, transient lesion pathology, all <br />                                            lines behaved identically (data shown). <br />  <br />                                            The ability WT pah&#226;&#710;&#8217; Leishmania survive peritoneal macrophages assessed <br />                                            following infection complement-opsonized stationary phase parasites. Parasitemia was <br />                                            monitored percent infected macrophages (Fig. 6C) number parasites 100 <br />                                            macrophages (Fig. 6D). Again, difference parasite survival seen. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                3.7. Metacyclogenesis <br />                                            Previously showed H4B levels associated increased differentiation the <br />                                            infective metacyclic form, occurs normally following entry stationary phase [44]. <br />                                            Since PAH activity affect H4B levels, explored effect PAH depletion or <br />                                            overexpression metacyclogenesis. Tests performed folate-depleted M199 media <br />                                            (fdM199) containing minimal (0.001 &#206;&#188;g/ml) saturating (2 &#206;&#188;g/ml) concentrations of <br />                                            biopterin. As before, differences growth rate observed, metacyclogenesis was <br />                                            elevated low-biopterin conditions (10&#226;&#8364;&#8220;11% vs 4.5 &#226;&#8364;&#8220; 5%; Fig. S2, data shown). <br />                                            However, differences seen metacyclogenesis WT pah&#226;&#710;&#8217; either <br />                                            condition (Fig. S2). Similar tests showed effect epinephrine (100 &#206;&#188;M), norepinephrine <br />                                            (100 &#206;&#188;M) propanolol (10 &#206;&#188;M) parasite growth differentiation, WT or <br />                                            pah&#226;&#710;&#8217; (Fig. S2). We conclude PAH presence potential downstream effectors <br />                                            arising PAH activity effect metacyclogenesis, grown the <br />                                            minimum level biopterin required support normal growth. <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                     Page 9 <br />  <br />  <br />                                3.8. Reactivity anti-Melanin antibody MAb 6D <br />                                            Melanin downstream metabolite AAAH activity species [45,46] used <br />                                            reactivity melanin antibody MAb 6D2 reveal presence Leishmania. While <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            WT parasites showed reactivity, comparable isotypic controls (Fig. 7A data shown), <br />                                            grown media containing 250 &#206;&#188;M DOPA, strong reactivity observed (Fig. 7C). In <br />                                            contrast, pah&#226;&#710;&#8217; parasites showed reactivity grown presence DOPA (Fig. 7B). <br />                                            Restoration PAH expression pah&#226;&#710;&#8217;/+PAH line restored MAb 6D2 reactivity (Fig. 7D). <br />                                            We observed experiments cells pigmented PAH-expressing <br />                                            cells grown presence DOPA. We sought confirm reactive material indeed <br />                                            melanin, using protocol solubilizes cellular components leaves insoluble <br />                                            melanin intact, unsuccessful WT cells grown presence DOPA (not <br />                                            shown). <br />  <br />                                4. Discussion <br />                                            In work identified explored potential roles L. major PAH. As unable <br />                                            express active PAH biochemical characterization, relied primarily predicted <br />                                            properties based PAH protein sequence, characterization pah&#226;&#710;&#8217; null <br />                                            mutant PAH overexpressor obtained following transfection multicopy episomal <br />                                            PAH expression vector. Collectively aromatic amino acid hydroxylase family shares many <br />                                            physical, structural catalytic properties [4,5,16]. The predicted L. major PAH protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            showed typical mammalian-type AAAH domain structure, highly conserved central <br />                                            catalytic core flanked conserved N terminal C terminal regions, implicated in <br />                                            regulatory oligomerization roles AAAHs (Fig. 1). The L. major PAH central <br />                                            catalytic core showed good conservation catalytic residues motifs seen AAAHs. <br />                                            Importantly, residues include responsible binding H4-biopterin. <br />  <br />                                            Several protozoans bear AAAH genes, including apicomplexan parasite <br />                                            Toxoplasma genes encoding potentially secreted Phe Trp hydroxylase <br />                                            activity [36], cellular slime mold Dictyostelium [47]. Phenylalanine hydroxylases also <br />                                            occur sporadically prokaryotes [4,18]. Evolutionarily, L. major PAH falls as <br />                                            expected near <span id='am-238' about='xsp:base' typeof='owl:Thing'>base</span> eukaryotic radiation (Fig. S3). While Leishmania species <br />                                            genomes reported date encode PAH ortholog, absent genomes African <br />                                            South American trypanosomes. Since PAH gene occurs free-living Kinetoplastid <br />                                            relative Bodo saltans (family Bodonidae; Fig. S3), infer PAH lost common <br />                                            ancestor trypanosomes following divergence Leishmania. However, genome <br />                                            African trypanosomes predicts PCD gene trypanosomes express high levels QDPR <br />                                            activity [13]. This consistent idea H4B required essential processes <br />                                            Leishmania trypanosomes, cofactor AAAH activity. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Characterization L. major pah&#226;&#710;&#8217; null mutant showed phenotypes firmly establishing the <br />                                            requirement PAH phenylalanine hydroxylase activity. While WT parasites converted <br />                                            radiolabeled Phe Tyr, pah&#226;&#710;&#8217; mutant unable (Fig. 4A, Table 1), and <br />                                            correspondingly, pah&#226;&#710;&#8217;/+PAH overexpressor showed elevated ability (Table 1). <br />                                            Despite activity, WT L. major auxotrophic Tyr Phe Trp (Fig. 5A&#226;&#8364;&#8220; <br />                                            C), suggesting WT PAH levels insufficient metabolic needs. Notably, WT and <br />                                            PAH overexpressing parasites showed reproducibly higher susceptibility Phe Trp <br />                                            deprivation Tyr deprivation (Fig. 5&#226;&#8364;&#8220;C). Moreover, pah&#226;&#710;&#8217;/+PAH episomal <br />                                            overexpressor showed partial growth inhibition, readily adapted normal <br />                                            growth Tyr (Fig. 5C, D). These data suggest WT PAH activity partially <br />                                            alleviate Tyr insufficiency, able facilitate <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-162' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span>cell survival</span> growth. The ability <br />                                            PAH overexpression rescue Tyr auxotrophy pah&#226;&#710;&#8217; mutant firmly establishes the <br />                                            PAH activity LmjPAH. <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                                  Page 10 <br />  <br />  <br />                                            In contrast PAH-dependent Phe hydroxylase activity, Tyr Trp hydroxylase activity <br />                                            detected vivo radiolabeling, using WT, pah&#226;&#710;&#8217; pah&#226;&#710;&#8217;/+PAH <br />                                            overexpressor. This consistent LmjPAH amino acid sequence, shows residues <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            typical AAAHs Phe Tyr hydroxylase activity (Fig. 1). <br />                                            Correspondingly, PAH expression levels did alter growth Phe Trp deprivation <br />                                            (Fig. 5A, B). These data suggest Leishmania PAH specific Phe. <br />  <br />                                4.1. A melanin-like substance Leishmania? <br />                                            Curiously, able reactivity Leishmania antibody melanin, <br />                                            dependent presence PAH exogenous DOPA (Fig. 7), some <br />                                            experiments Leishmania appeared pigmented. However, failed recover insoluble <br />                                            acid-resistant pigment characteristic melanin [30], suggesting reactive substance <br />                                            unlikely authentic melanin. A number melanin-like substances been <br />                                            described, arising variety diphenolic precursors [48]. In fungus <br />                                            Cryptococcus neoformans, melanin plays important roles virulence [45]. However, since <br />                                            Leishmania requires PAH make melanin-like substance, does require PAH for <br />                                            differentiation infectivity mice macrophages (Fig. 7), role melanin-like <br />                                            substance Leishmania virulence unlikely. <br />  <br />                                4.2. PAH null mutants remain viable virulent <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Given importance H4B Leishmania viability virulence, melanin-like <br />                                            substances implicated host-pathogen interactions species [36,46,49], <br />                                            asked PAH-dependent metabolites played role Leishmania infectious cycle. <br />                                            First examined ability parasite differentiate infectious metacyclic parasites <br />                                            vitro, process known up-regulated low H4B levels L. major [44]. We confirmed <br />                                            result, virulent L. major FV1 line studied here, percent metacyclics identical <br />                                            WT pah&#226;&#710;&#8217; lines grown high minimal biopterin levels, nor <br />                                            altered presence downstream metabolites including catecholamines inhibitors <br />                                            (Figure S2). Similarly, pah&#226;&#710;&#8217; line behaved identically WT following infections primary <br />                                            macrophages vitro, infections susceptible resistant mice vivo (Fig. 6 data <br />                                            shown). Finally, preliminary studies pah&#226;&#710;&#8217; line survived sand flies, the <br />                                            insect vector leishmaniasis (D. Sacks, L-FL SMB, unpublished data). <br />  <br />                                            Thus, circumstances PAH partially mitigate Tyr growth requirement <br />                                            L. major, essential normal growth virulence Leishmania infective <br />                                            cycle. Similarly, PAH gene absent trypanosomes, like Leishmania require <br />                                            H4B [50]. Future studies consider metabolic roles PAH, Phe <br />                                            anabolism, drug resistance metabolic pathways thioether metabolism [45, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            51]. However, pah&#226;&#710;&#8217; mutant grows normally vitro vivo, unlikely <br />                                            PAH activity PAH-dependent metabolites account completely strong <br />                                            biopterin growth requirement Leishmania. <br />  <br />                                Supplementary Material <br />                                            Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                                Acknowledgments <br />                                            We thank A. H. Fairlamb (U. Dundee) A. Hanson (U. Florida Gainesville) discussions, S. C. Daubner P.F. <br />                                            Fitzpatrick (Texas A&amp;M University) A. Pribat (U. Florida Gainesville) assistance advice attempts to <br />                                            express active LmjPAH, S. Hickerson instruction mouse infectivity tests macrophage infections, D.L. Sacks <br />                                            (NIH) preliminary studies sand fly infectivity, Tim J. Vickers comments manuscript. This work <br />                                            supported National Institutes Health Grants AI21903 (L-FL, SOK, SMB) AI52733 (AC, JDN). <br />  <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                      Page 11 <br />  <br />  <br />                                Abbreviations <br />                                         PAH                            phenylalanine hydroxylase <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         AAAH                           aromatic amino acid hydroxylase <br />                                         LmjPAH/LmPAH                   Leishmania major phenylalanine hydroxylase gene/enzyme <br />                                         H2B                            dihydrobiopterin <br />                                         H4B                            tetrahydrobiopterin <br />                                         bp                             base pair(s) <br />                                         ORF                            open reading frame <br />                                         nt                             nucleotide(s) <br />                                         PCR                            polymerase chain reaction <br />                                         Phe                            phenylalanine <br />                                         Tyr                            tyrosine <br />                                         Trp                            tryptophan <br />                                         WT                             wild-type <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         L-DOPA                         L-dihydroxyphenylalanine <br />  <br />                                References <br />                                              1. Desjeux P. Leishmaniasis: current situation new perspectives. Comparative immunology, <br />                                                 microbiology infectious diseases 2004;27:305&#226;&#8364;&#8220;18. <br />                                              2. Sacks D, Noben-Trauth N. The immunology susceptibility resistance Leishmania major in <br />                                                 mice. Nature Immunol 2002;2:845&#226;&#8364;&#8220;58. <br />                                              3. Opperdoes FR, Coombs GH. Metabolism Leishmania: proven predicted. Trends Parasitol <br />                                                 2007;23:149&#226;&#8364;&#8220;58. [PubMed: 17320480] <br />                                              4. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration functions. Biochem <br />                                                 J 2000;347(Pt 1):1&#226;&#8364;&#8220;16. [PubMed: 10727395] <br />                                              5. Werner-Felmayer G, Golderer G, Werner ER. Tetrahydrobiopterin biosynthesis, utilization and <br />                                                 pharmacological effects. Curr Drug Metab 2002;3:159&#226;&#8364;&#8220;73. [PubMed: 12003348] <br />                                              6. Petrillo-Peixoto M, Beverley SM. In vitro activity sulfonamides sulfones Leishmania <br />                                                 major promastigotes. Antimicrob Agents Chemother 1987;31:1575&#226;&#8364;&#8220;8. [PubMed: 3435106] <br />                                              7. Beck JT, Ullman B. Nutritional requirements wild-type folate transport-deficient Leishmania <br />                                                 donovani pterins folates. Mol Biochem Parasitol 1990;43:221&#226;&#8364;&#8220;30. [PubMed: 2090944] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              8. Kundig C, Haimeur A, Legare D, Papadopoulou B, Ouellette M. Increased transport pteridines <br />                                                 compensates mutations high affinity folate transporter contributes methotrexate <br />                                                 resistance protozoan parasite Leishmania tarentolae. EMBO J 1999;18:2342&#226;&#8364;&#8220;51. [PubMed: <br />                                                 10228149] <br />                                              9. Cunningham ML, Beverley SM. Pteridine salvage Leishmania infectious cycle: <br />                                                 implications antifolate chemotherapy. Mol Biochem Parasitol 2001;113:199&#226;&#8364;&#8220;213. [PubMed: <br />                                                 11295174] <br />                                              10. Bello AR, Nare B, Freedman D, Hardy L, Beverley SM. PTR1: reductase mediating salvage of <br />                                                   oxidized pteridines methotrexate resistance protozoan parasite Leishmania major. Proc <br />                                                   Natl Acad Sci U S A 1994;91:11442&#226;&#8364;&#8220;6. [PubMed: 7972081] <br />                                              11. Ouellette M, Drummelsmith J, El-Fadili A, Kundig C, Richard D, Roy G. Pterin transport and <br />                                                   metabolism Leishmania related trypanosomatid parasites. Int J Parasitol 2002;32:385&#226;&#8364;&#8220;98. <br />                                                   [PubMed: 11849635] <br />  <br />  <br />  <br />  <br />                                              Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                  Page 12 <br />  <br />  <br />                                         12. Nare B, Luba J, Hardy LW, Beverley S. New approaches Leishmania chemotherapy: pteridine <br />                                             reductase 1 (PTR1) target modulator antifolate sensitivity. Parasitology 1997;114 <br />                                             (Suppl):S101&#226;&#8364;&#8220;10. [PubMed: 9309772] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         13. Lye LF, Cunningham ML, Beverley SM. Characterization quinonoid-dihydropteridine reductase <br />                                             (QDPR) lower eukaryote Leishmania major. J Biol Chem 2002;277:38245&#226;&#8364;&#8220;53. [PubMed: <br />                                             12151409] <br />                                         14. Naponelli V, Noiriel A, Ziemak MJ, Beverley SM, Lye LF, Plume AM, et al. Phylogenomic and <br />                                             functional analysis pterin-4a-carbinolamine dehydratase family (COG2154) proteins plants and <br />                                             microorganisms. Plant Physiol 2008;146:1515&#226;&#8364;&#8220;27. [PubMed: 18245455] <br />                                         15. Nare B, Garraway LA, Vickers TJ, Beverley SM. PTR1-dependent synthesis tetrahydrobiopterin <br />                                             contributes oxidant susceptibility trypanosomatid protozoan parasite Leishmania major. <br />                                             Curr Genet 2009;55:287&#226;&#8364;&#8220;99. [PubMed: 19396443] <br />                                         16. Fitzpatrick PF. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem <br />                                             1999;68:355&#226;&#8364;&#8220;81. [PubMed: 10872454] <br />                                         17. Hufton SE, Jennings IG, Cotton RG. Structure function aromatic amino acid hydroxylases. <br />                                             Biochem J 1995;311 (Pt 2):353&#226;&#8364;&#8220;66. [PubMed: 7487868] <br />                                         18. Zhao G, Xia T, Song J, Jensen RA. Pseudomonas aeruginosa possesses homologues mammalian <br />                                             phenylalanine hydroxylase 4 alpha-carbinolamine dehydratase/DCoH three- <br />                                             component gene cluster. Proc Natl Acad Sci U S A 1994;91:1366&#226;&#8364;&#8220;70. [PubMed: 8108417] <br />                                         19. Nare B, Hardy LW, Beverley SM. The roles pteridine reductase 1 dihydrofolate reductase- <br />                                             thymidylate synthase pteridine metabolism protozoan parasite Leishmania major. J Biol <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Chem 1997;272:13883&#226;&#8364;&#8220;91. [PubMed: 9153248] <br />                                         20. da Silva R, Sacks DL. Metacyclogenesis major determinant Leishmania promastigote virulence <br />                                             attenuation. Infect Immun 1987;55:2802&#226;&#8364;&#8220;6. [PubMed: 3666964] <br />                                         21. Kapler GM, Coburn CM, Beverley SM. Stable transfection human parasite Leishmania <br />                                             major delineates 30-kilobase region sufficient extrachromosomal replication expression. <br />                                             Mol Cell Biol 1990;10:1084&#226;&#8364;&#8220;94. [PubMed: 2304458] <br />                                         22. Medina-Acosta E, Cross GA. Rapid isolation DNA trypanosomatid protozoa using simple <br />                                             &#226;&#8364;&#732;mini-prep&#226;&#8364;&#8482; procedure. Mol Biochem Parasitol 1993;59:327&#226;&#8364;&#8220;9. [PubMed: 8341329] <br />                                         23. Sambrook, J.; Fritsch, EF.; Maniatis, T. Molecular cloning: laboratory manual. Cold Spring Harbor <br />                                             Laboratory Press; 1989. Molecular cloning: laboratory manual; p. 1-1000. <br />                                         24. Akopyants NS, Clifton SW, Martin J, Pape D, Wylie T, Li L, et al. A survey Leishmania <br />                                             major Friedlin strain V1 genome shotgun sequencing: resource DNA microarrays and <br />                                             expression profiling. Mol Biochem Parasitol 2001;113:337&#226;&#8364;&#8220;40. [PubMed: 11295190] <br />                                         25. Ryan KA, Dasgupta S, Beverley SM. Shuttle cosmid vectors trypanosomatid parasite <br />                                             Leishmania. Gene 1993;131:145&#226;&#8364;&#8220;50. [PubMed: 8370535] <br />                                         26. Ha DS, Schwarz JK, Turco SJ, Beverley SM. Use green fluorescent protein marker in <br />                                             transfected Leishmania. Mol Biochem Parasitol 1996;77:57&#226;&#8364;&#8220;64. [PubMed: 8784772] <br />                                         27. Cruz A, Coburn CM, Beverley SM. Double targeted gene replacement creating null mutants. Proc <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Natl Acad Sci U S A 1991;88:7170&#226;&#8364;&#8220;4. [PubMed: 1651496] <br />                                         28. Goyard S, Beverley SM. Blasticidin resistance: new independent marker stable transfection of <br />                                             Leishmania. Mol Biochem Parasitol 2000;108:249&#226;&#8364;&#8220;52. [PubMed: 10838227] <br />                                         29. Coppi A, Merali S, Eichinger D. The enteric parasite Entamoeba uses autocrine catecholamine <br />                                             differentiation infectious cyst stage. J Biol Chem 2002;277:8083&#226;&#8364;&#8220;90. <br />                                             [PubMed: 11779874] <br />                                         30. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of <br />                                             polymerized melanin Cryptococcus neoformans infected rodents. Infect Immun 2000;68:2845&#226;&#8364;&#8220; <br />                                             53. [PubMed: 10768981] <br />                                         31. Glatman-Freedman A, Martin JM, Riska PF, Bloom BR, Casadevall A. Monoclonal antibodies to <br />                                             surface antigens Mycobacterium tuberculosis use modified enzyme-linked <br />                                             immunosorbent spot assay detection mycobacteria. J Clin Microbiol 1996;34:2795&#226;&#8364;&#8220;802. <br />                                             [PubMed: 8897185] <br />                                         32. Titus RG, Muller I, Kimsey P, Cerny A, Behin R, Zinkernagel RM, et al. Exacerbation experimental <br />                                             murine cutaneous leishmaniasis CD4+ Leishmania major-specific T cell lines clones which <br />  <br />  <br />                                         Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                                  Page 13 <br />  <br />  <br />                                              secrete interferon-gamma mediate parasite-specific delayed-type hypersensitivity. Eur J <br />                                              Immunol 1991;21:559&#226;&#8364;&#8220;67. [PubMed: 1672641] <br />                                         33. Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay quantifying Leishmania <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              major tissues infected mice. Parasite Immunol 1985;7:545&#226;&#8364;&#8220;55. [PubMed: 3877902] <br />                                         34. Spath GF, Epstein L, Leader B, Singer SM, Avila HA, Turco SJ, et al. Lipophosphoglycan a <br />                                              virulence factor distinct related glycoconjugates protozoan parasite Leishmania major. <br />                                              Proc Natl Acad Sci U S A 2000;97:9258&#226;&#8364;&#8220;63. [PubMed: 10908670] <br />                                         35. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, et al. The genome the <br />                                              kinetoplastid parasite, Leishmania major. Science 2005;309:436&#226;&#8364;&#8220;42. [PubMed: 16020728] <br />                                         36. Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA. A unique dual activity amino acid <br />                                              hydroxylase Toxoplasma gondii. PLoS One 2009;4:e4801. [PubMed: 19277211] <br />                                         37. Ramsey AJ, Daubner SC, Ehrlich JI, Fitzpatrick PF. Identification iron ligands tyrosine <br />                                              hydroxylase mutagenesis conserved histidinyl residues. Protein Sci 1995;4:2082&#226;&#8364;&#8220;6. [PubMed: <br />                                              8535244] <br />                                         38. Erlandsen H, Bjorgo E, Flatmark T, Stevens RC. Crystal structure site-specific mutagenesis of <br />                                              pterin-bound human phenylalanine hydroxylase. Biochemistry 2000;39:2208&#226;&#8364;&#8220;17. [PubMed: <br />                                              10694386] <br />                                         39. Dickson PW, Jennings IG, Cotton RG. Delineation catalytic core phenylalanine hydroxylase <br />                                              identification glutamate 286 critical residue pterin function. J Biol Chem <br />                                              1994;269:20369&#226;&#8364;&#8220;75. [PubMed: 7914195] <br />                                         40. Jiang GC, Yohrling GJt, Schmitt JD, Vrana KE. Identification substrate orienting and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              phosphorylation sites tryptophan hydroxylase using homology-based molecular modeling. J <br />                                              Mol Biol 2000;302:1005&#226;&#8364;&#8220;17. [PubMed: 10993738] <br />                                         41. Daubner SC, Melendez J, Fitzpatrick PF. Reversing substrate specificities phenylalanine and <br />                                              tyrosine hydroxylase: aspartate 425 tyrosine hydroxylase essential L-DOPA formation. <br />                                              Biochemistry 2000;39:9652&#226;&#8364;&#8220;61. [PubMed: 10933781] <br />                                         42. Liang XH, Haritan A, Uliel S, Michaeli S. trans cis splicing trypanosomatids: mechanism, <br />                                              factors, regulation. Eukaryot Cell 2003;2:830&#226;&#8364;&#8220;40. [PubMed: 14555465] <br />                                         43. Steiger RF, Steiger E. Cultivation Leishmania donovani Leishmania braziliensis defined <br />                                              media: nutritional requirements. J Protozool 1977;24:437&#226;&#8364;&#8220;41. [PubMed: 915847] <br />                                         44. Cunningham ML, Titus RG, Turco SJ, Beverley SM. Regulation differentiation infective <br />                                              stage protozoan parasite Leishmania major tetrahydrobiopterin. Science 2001;292:285&#226;&#8364;&#8220;7. <br />                                              [PubMed: 11303103] <br />                                         45. Nosanchuk JD, Casadevall A. Impact melanin microbial virulence clinical resistance to <br />                                              antimicrobial compounds. Antimicrob Agents Chemother 2006;50:3519&#226;&#8364;&#8220;28. [PubMed: 17065617] <br />                                         46. Christensen BM, Li J, Chen CC, Nappi AJ. Melanization immune responses mosquito vectors. <br />                                              Trends Parasitol 2005;21:192&#226;&#8364;&#8220;9. [PubMed: 15780842] <br />                                         47. Siltberg-Liberles J, Steen IH, Svebak RM, Martinez A. The phylogeny aromatic amino acid <br />                                              hydroxylases revisited characterizing phenylalanine hydroxylase Dictyostelium <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              discoideum. Gene 2008;427:86&#226;&#8364;&#8220;92. [PubMed: 18835579] <br />                                         48. Plonka PM, Grabacka M. Melanin synthesis microorganisms--biotechnological medical <br />                                              aspects. Acta Biochim Pol 2006;53:429&#226;&#8364;&#8220;43. [PubMed: 16951740] <br />                                         49. Casadevall A, Rosas AL, Nosanchuk JD. Melanin virulence Cryptococcus neoformans. Curr <br />                                              Opin Microbiol 2000;3:354&#226;&#8364;&#8220;8. [PubMed: 10972493] <br />                                         50. Sienkiewicz N, Ong HB, Fairlamb AH. Trypanosoma brucei pteridine reductase 1 essential for <br />                                              survival vitro virulence mice. Mol Microbiol. 2010 <br />                                         51. Steventon GB, Mitchell SC. Phenylalanine 4-monooxygenase role endobiotic metabolism <br />                                              enzymes xenobiotic biotransformation. Expert Opin Drug Metab Toxicol 2009;5:1213&#226;&#8364;&#8220;21. <br />                                              [PubMed: 19653802] <br />  <br />  <br />  <br />  <br />                                         Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                          Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 1. Alignment L. major PAH human phenylalanine, tyrosine tryptophan <br />                                         hydroxylases <br />                                         The predicted amino acid sequence L. major PAH (Lmaj) aligned human <br />                                         phenylalanine, tryptophan tyrosine hydroxylase (HsPheH, TyrH TrpH; accession <br />                                         numbers provided legend Fig. S3). Residues identical sequences <br />                                         highlighted gray boxes. Residues implicated iron binding marked &#226;&#8212;?, residues <br />                                         implicated substrate cofactor binding &#226;&#8211;&#188;, residues associated amino acid <br />                                         specificity &#226;&#8212;&#8225;. The presumptive N terminal &#226;&#8364;&#732;regulatory&#226;&#8364;&#8482; C-terminal &#226;&#8364;&#732;oligomerization&#226;&#8364;&#8482; <br />                                         domains marked solid box, region homologous pteridine binding <br />                                         region AAAH marked dashed box. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Mol Biochem Parasitol. Author manuscript; available PMC 2012 January 1. <br />                             Lye et al.                                                                                       Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 2. Expression PAH mRNA Leishmania major infectious cycle <br />                                         Northern blot analysis total RNAs probed LmPAH coding region sequence are <br />                                         shown. The autoradiogram shown upper panel single ~ 4-kb LmPAH <br />                                         transcript. Molecular size markers (kb) shown left. The lower panel shows the <br />                                         ethidium bromide-stained gel showing rRNAs loading control. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          <br /> </body></html>